Show Summary Details
Page of

Psychopharmacology and refugees, asylum seekers, and migrants 

Psychopharmacology and refugees, asylum seekers, and migrants
Psychopharmacology and refugees, asylum seekers, and migrants

David C. Henderson

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 07 May 2021

Refugee, asylum seeker, and migrant populations may have experienced many adverse life events during time in their country and during the time of migration. As a result, many will experience common mental health problems, including anxiety, post-traumatic stress disorder, and depression. This chapter reviews the genetic and environmental factors that impact pharmacological interventions for the common mental health problems of these groups. Cultural and explanatory models may play a role in help-seeking, as well as therapeutic alliances and adherence. Cultures may carry different explanations for the use of medication. Pharmacodynamics and pharmacokinetic properties will vary across cultures. These will be affected by dietary factors, as well as genetic and biological factors. Recommendations are also included regarding the safe and effective approaches for treating these groups of patients with psychotropic medications.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.